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Waterborne	  pathogens	  are	  increasingly	  a	  worldwide	  concern	  in	  drinking	  water	  because	  of	  their	  
ability	  to	  cause	  high	  levels	  of	  morbidity	  and	  mortality.	  Especially	  in	  developing	  regions,	  a	  lack	  of	  
access	   to	   safe	   drinking	   water,	   adequate	   sanitation,	   and	   resources	   to	   implement	   water	  
treatment	  processes	  contributes	  to	  the	  spread	  of	  pathogens.	  	  	  Emerging	  pathogens	  are	  also	  of	  
concern	   in	   water	   treatment	   for	   communities	   in	   developed	   regions	   as	   they	   can	   be	   highly	  
resistant	   to	   specific	   treatment	   technologies.	   	   Viruses	   are	   of	   particular	   concern	   in	   water	  
treatment	  not	  only	  because	  of	  their	  virulence	  and	  ability	  to	  have	  high	  resistance	  to	  inactivation,	  
but	  also	  because	  of	  the	  limited	  knowledge	  available.	  	  Human	  pathogenic	  viruses	  are	  not	  easy	  to	  
study	   in	   the	   laboratory	   or	   in	   the	   field	   because	   of	   strict	   biosafety	   regulations	   and	   the	   use	   of	  
expensive	  cell	   culture	  methods	   that	  are	   time	  consuming.	   	  Often	   it	   is	  not	  practical	   to	  perform	  
testing	  with	   human	   pathogens,	   and	   therefore	   surrogates	   can	   be	   used.	   	   Currently,	   there	   is	   a	  
need	  to	  develop	  proper	  surrogates	  especially	  for	  adenovirus,	  a	  human	  enteric	  pathogen	  found	  
globally	   in	  drinking	  water	  sources.	   	  Adenovirus	   is	  known	  to	  be	  highly	   resistant	   to	  disinfection	  
technologies	   such	   as	   ultraviolet	   (UV)	   light,	   combined	   chlorine,	   and	   solar	   disinfection.	   	   A	  
potential	   surrogate	   for	   adenovirus	   is	   the	   bacteriophage	   PRD1	   because	   of	   its	   similar	   size,	  
morphology,	   and	   genome	   replication	   mechanism.	   	   The	   objective	   of	   this	   research	   was	   to	  
compare	   the	   inactivation	   kinetics	   of	   PRD1	   with	   that	   of	   adenovirus	   when	   exposed	   to	   free	  
chlorine,	   low	   pressure	   ultraviolet	   light,	   and	   solar	   disinfection	   to	   determine	   if	   PRD1	   is	   an	  
appropriate	  surrogate.	  	  	  Using	  PRD1	  as	  a	  surrogate	  would	  enable	  field	  testing	  to	  determine	  the	  
efficacy	  of	   current	   and	  emerging	  water	   treatment	   technologies,	  more	   rapid	   and	  non	   virulent	  
laboratory	   experiments,	   and	   the	   use	   of	   a	   surrogate	   for	   determining	   the	   mechanisms	   of	  
inactivation	  of	  adenovirus.	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CHAPTER	  1	  INTRODUCTION	  
	  
	  
Waterborne	  pathogens	  are	  increasingly	  a	  worldwide	  concern	  in	  drinking	  water	  because	  of	  their	  
ability	  to	  cause	  high	  levels	  of	  morbidity	  and	  mortality.	  	  Especially	  in	  developing	  regions,	  a	  lack	  of	  
access	   to	   safe	   drinking	   water,	   adequate	   sanitation,	   and	   resources	   to	   implement	   water	  
treatment	  processes	  contributes	  to	  the	  spread	  of	  pathogens.	  	  Without	  adequate	  protection	  of	  
drinking	  water	  sources,	  waters	  can	  become	  heavily	  contaminated	  by	  human	  and	  animal	  waste	  
which	  contributes	  to	  the	  spread	  of	  a	  range	  of	  pathogens	  including	  viruses.	  	  The	  United	  Nations	  
(UN)	  Millennium	  Development	  Goal	  (MDG)	  7	  seeks	  to	  “halve,	  by	  2015,	  the	  proportion	  of	  people	  
without	  sustainable	  access	  to	  safe	  drinking	  water	  and	  sanitation”	  and	  the	  indicator	  used	  is	  the	  
“proportion	   of	   population	   using	   an	   improved	   drinking	   water	   source,	   urban,	   and	   rural”	   (UN,	  
2003).	   	   	  A	  recent	  update	  on	  MDG	  7	  by	  the	  World	  Health	  Organization	  (WHO)	  details	  that	  884	  
million	   people	   still	   lack	   access	   to	   improved	   drinking	  water	   sources	   (WHO,	   2010).	   	   The	  WHO	  
report	   and	   a	   recent	   report	   by	   the	   UN’s	   Independent	   Expert	   on	   the	   issue	   of	   human	   rights	  
obligations	   related	   to	   access	   to	   safe	   drinking	   water	   and	   sanitation	   further	   emphasize	   that	  
improved	  drinking	  water	  sources	  may	  not	  meet	  drinking	  water	  quality	  standards,	  and	  therefore	  
the	  number	  of	  people	  worldwide	  who	  lack	  access	  to	  safe	  drinking	  water	  is	  indeed	  much	  greater	  
(de	  Albuquerque,	  2010).	   	  Because	  of	  the	  high	  prevalence	  of	  waterborne	  diseases,	  current	  and	  
emerging	  technologies	  for	  water	  disinfection	  are	   important	  to	  study	   in	  these	  areas.	   	  Point-­‐of-­‐
use	   disinfection	   technologies	   are	   a	   viable	   treatment	   method	   in	   developing	   regions	   and	  
implementation	   has	   showed	   an	   improvement	   in	   health	   and	   the	   potential	   for	   a	   sustainable	  
solution;	  however,	  many	  systems	  currently	  used	  are	  not	  always	  completely	  effective	   in	   these	  
challenging	  surface	  waters	  common	  to	  developing	  regions.	  	  Small	  community	  scale	  systems	  are	  
also	  common	  in	  developing	  regions,	  but	  sometimes	  do	  not	  have	  adequate	  disinfection	  steps	  to	  
prevent	  the	  spread	  of	  disease.	  	  
	  
Emerging	   pathogens	   are	   also	   of	   concern	   in	   water	   treatment	   for	   communities	   in	   developed	  
regions	   as	   they	   can	   be	   highly	   resistant	   to	   specific	   treatment	   technologies.	   	   There	   have	   been	  
recent	   changes	   in	  water	   disinfection	   regulations	   by	   the	  US	   Environmental	   Protection	   Agency	  
	   	  	  	  2	  
(USEPA)	  with	   the	   Long	  Term	  2	  Enhanced	  Surface	  Water	   Treatment	  Rule	   (LT2ESWTR)	  and	   the	  
Stage	  2	  Disinfectants	  and	  DBPs	  Rule	  (Stage	  2	  DBPR)	  (USEPA,	  2006	  a,b).	  	  An	  increasing	  number	  of	  
utilities	  have	  since	  been	  switching	  from	  the	  common	  disinfection	  strategy	  of	  using	  free	  chlorine	  
as	  a	  primary	  and	  residual	  disinfectant	  to	  the	  use	  of	  different	  disinfection	  strategies	  to	  comply	  
with	   new	   regulations.	   	   The	   LT2ESWTR	   requires	   a	   more	   robust	   treatment	   for	   inactivating	  
Cryptosporidium	   parvum	   oocysts,	   which	   are	   highly	   resistant	   to	   free	   chlorine.	   	   The	   use	   of	  
ultraviolet	   (UV)	   light	   is	   an	   effective	   disinfectant	   for	   the	   oocysts;	   however,	   the	   UV	   dosages	  
commonly	  used	  for	  oocysts	  would	  not	  be	  adequate	  to	   inactivate	  certain	  viruses.	   	  The	  Stage	  2	  
DBPR	  has	   also	   influenced	   the	  movement	   away	   from	   free	   chlorine	  because	   the	   rule	   regulates	  
several	   trihalomethanes	   and	   haloacetic	   acids	   that	   are	   mostly	   associated	   with	   free	   chlorine	  
disinfection.	   	  The	  use	  of	   combined	  chlorine	  as	  a	   residual	  disinfectant	   for	  distribution	  systems	  
has	   been	   implemented	   by	   utilities	   to	   lower	   their	   amount	   of	   regulated	   DBPs	   in	   the	   finished	  
water.	   	  With	   the	  new	   regulations,	   viruses	  have	  become	  emerging	  pathogens	  because	   certain	  
viruses	  can	  be	  highly	  resistant	  to	  both	  UV	  and	  combined	  chlorine	  treatment.	  	  	  
	  
Viruses	   are	  of	   particular	   concern	   in	  water	   treatment	  not	  only	   because	  of	   their	   virulence	   and	  
ability	   to	   have	   high	   resistance	   to	   inactivation,	   but	   also	   because	   of	   the	   limited	   knowledge	  
available.	  	  Viruses	  pathogenic	  to	  humans	  are	  not	  easy	  to	  study	  in	  the	  laboratory	  or	  in	  the	  field	  
because	  of	  strict	  biosafety	  regulations.	  	  Additionally,	  quantification	  of	  infectious	  human	  viruses	  
typically	   require	   the	   use	   of	   cell	   cultures	  which	   are	   time	   consuming	   to	   propagate,	   expensive,	  
easily	  contaminated,	  and	  require	  specific	  conditions	  for	  growth	  that	  can	  be	  nearly	  impossible	  to	  
achieve	   in	   regions	   that	  have	   intermittent	  or	  no	   access	   to	   electricity.	   	  When	   studying	   viruses,	  
pure	   cultures	   and	   proper	   biosafety	   standards	   can	   be	   effectively	   controlled	   in	   a	   laboratory	  
setting;	   however,	  when	  working	   in	   the	   field,	   it	   is	   often	   not	   practical	   to	   perform	   testing	  with	  
human	  pathogens	  so	  surrogates	  can	  be	  used.	   	  One	  of	   the	  most	  commonly	  used	  surrogates	   is	  
the	  single-­‐stranded	  RNA	  bacteriophage	  MS2,	  which	  does	  not	  show	  similar	  inactivation	  to	  many	  
human	  viruses	  including	  adenovirus	  for	  a	  range	  of	  disinfectants.	  	  Because	  of	  these	  challenges,	  
there	  is	  a	  need	  to	  identify	  appropriate	  viral	  pathogen	  surrogates	  for	  testing	  the	  robustness	  of	  
treatment	  technologies	  in	  the	  field	  and	  laboratory.	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A	   human	   pathogenic	   double-­‐stranded	   DNA	   virus,	   adenovirus,	   is	   present	   globally	   in	   drinking	  
water	  sources	  and	  can	  be	  spread	  through	  the	  fecal	  oral	  route	  or	  through	  aerosols	  (Jiang,	  2006).	  	  
There	   are	   51	   serotypes	   of	   human	   adenovirus	   that	   cause	   a	   variety	   of	   human	   health	   effects	  
including	   gastroenteritis,	   respiratory	   disease,	   and	   conjunctivitis	   (Jiang,	   2006).	   	   Adenovirus	   is	  
known	   to	   be	   highly	   resistant	   to	   disinfection	   technologies	   such	   as	   ultraviolet	   (UV)	   light,	  
combined	   chlorine,	   and	   solar	   disinfection	   (SODIS)	   (Sirikanchana	   et	   al.,	   2008).	   	   In	   contrast,	   a	  
study	  characterizing	   the	   inactivation	  kinetics	  of	  adenovirus	   serotype	  2	  with	   free	  chlorine	  at	  a	  
range	   of	   temperatures	   and	   pH	   (Page	   et	   al.,	   2009)	   has	   revealed	   that	   free	   chlorine	   is	   highly	  
effective	   in	   controlling	   adenovirus.	   	   As	   the	   water	   industry	   moves	   away	   from	   free	   chlorine,	  
further	   research	   is	   necessary	   on	   alternative	   disinfection	   schemes	   because	   the	   switch	   in	  
technologies	   are	   making	   adenovirus,	   as	   well	   as	   several	   enteroviruses,	   emerging	   pathogens.	  	  
Such	   research	   efforts	   should	   also	   focus	   on	   providing	   safe	   water	   in	   developing	   regions	   with	  	  
prevalence	   of	   waterborne	   diseases.	   	   Currently,	   specific	   enteric	   viruses	   are	   not	   regulated;	  
however,	  adenovirus	  is	  present	  on	  the	  EPA’s	  Contaminant	  Candidate	  List	  3	  with	  a	  potential	  for	  
future	  regulation	  (USEPA,	  2009).	  	  
	  
PRD1	   was	   chosen	   as	   a	   potential	   surrogate	   for	   adenovirus	   because	   of	   their	   strikingly	   similar	  
morphologies	  and	  genome	  replication	  mechanisms.	  	  Additionally,	  it	  has	  been	  hypothesized	  that	  
the	  two	  viruses	  are	  evolutionarily	  related	  (Benson	  et	  al.,	  1999).	   	  PRD1	  is	  a	  bacteriophage	  that	  
infects	  gram-­‐negative	  bacteria	  carrying	  P,	  N,	  or	  W	  incompatibility	  group	  plasmids.	  	  Accordingly,	  
PRD1	   has	   a	   range	   of	   hosts	   including	   Escherichia	   coli,	   Salmonella	   typhimurium,	   and	  
Pseudomonas	  aeruginosa.	  The	  viruses	  have	  very	  similar	   icosahedral	  capsid	  structures	  and	  are	  
the	   only	   virions	   to	   contain	   a	   pseudo	   T=25	   lattice	   structure.	   	   PRD1	   and	   adenovirus	   have	  
comparable	  diameter	  sizes	  of	  63	  and	  90nm,	  respectively.	  	  The	  coat	  proteins	  and	  vertex	  proteins	  
have	  related	  structures,	  and	  each	  virus	  has	  fiber	  protrusions	  from	  each	  of	  their	  12	  vertices	  on	  
the	  protein	  coat.	   	  Upon	  host	   infection,	   the	  DNA	  of	  both	  viruses	   is	   released	   through	  a	  vertex.	  	  
Furthermore,	   both	   viruses	   have	   linear	   double-­‐stranded	   DNA	   genomes	   that	   contain	   inverted	  
terminal	   repeat	   sequences,	   and	   they	   both	   use	   a	   protein	   primed	   mechanism	   for	   genome	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replication,	  and	  contain	  a	  5’	  terminal	  protein.	  	  The	  main	  structural	  difference	  between	  the	  two	  
viruses	   is	   that	   PRD1	   contains	   an	   internal	   lipid	   membrane	   derived	   from	   the	   bacterial	   host	  
membrane	  whereas	  adenovirus	  does	  not	   (Benson	  et	   al.,	   1999).	   	  Because	  of	   these	   similarities	  
particularly	  in	  structure	  and	  genome,	  PRD1	  could	  potentially	  exhibit	  similar	  inactivation	  kinetics	  
as	   adenovirus	   when	   exposed	   to	   varying	   disinfectants	   for	   water	   treatment	   especially	   when	  
compared	  to	  other	  surrogates	  currently	  used	  like	  the	  single-­‐stranded	  RNA	  bacteriophage	  MS2.	  	  	  
	  
The	  objective	  of	   this	   research	  was	  to	   investigate	   if	  PRD1	   is	  a	  proper	  surrogate	   for	  adenovirus	  
serotype	  2	  when	  exposed	  to	  chemical	  disinfectants,	  ultraviolet	   light,	  and	  sunlight	  through	  the	  
comparison	  of	  inactivation	  kinetics.	   	  Since	  the	  two	  viruses	  have	  such	  similar	  capsid	  structures,	  
using	  PRD1	  as	  a	  surrogate	  for	  adenovirus	  may	  help	  to	  elucidate	  mechanisms	  of	  inactivation	  of	  
adenovirus.	   	   Elucidating	   the	   mechanism	   of	   inactivation	   of	   the	   virus	   could	   then	   lead	   to	   the	  
development	  of	  more	  robust	  drinking	  water	  disinfection	  technologies	  and	  the	  development	  of	  
sensors	  to	  detect	  infective	  viruses	  in	  drinking	  water.	  	  If	  this	  surrogate-­‐host	  combination	  is	  able	  
to	  exhibit	  similar	  inactivation	  kinetics	  in	  the	  laboratory	  setting	  as	  the	  target	  viral	  pathogen,	  then	  
PRD1	   could	   be	   safely	   used	   in	   the	   field	   to	   determine	   the	   efficacy	   of	   existing	   and	   emerging	  
disinfectant	   techniques	   against	   adenovirus.	   	   Identifying	   a	   surrogate	   would	   be	   exceptionally	  
useful	  for	  furthering	  laboratory	  research	  and	  for	  improving	  drinking	  water	  disinfection	  systems	  
globally.	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CHAPTER	  2	  MATERIALS	  AND	  METHODS	  
	  
	  
2.1	  	  PRD1	  Propagation	  and	  Viability	  Assessment	  
	  
Bacteriophage	  PRD1	  (BAA-­‐769-­‐B1)	  and	   its	  bacterial	  hosts	  Escherichia	  coli	  K12	  J53-­‐1	  (BAA-­‐769)	  
and	   Salmonella	   typhimurium	   LT2	   (19585)	   were	   obtained	   from	   the	   American	   Type	   Culture	  
Collection	  (Manassas,	  Virginia).	  	  The	  freeze	  dried	  E.	  coli	  was	  rehydrated	  with	  autoclaved	  Tryptic	  
Soy	  Broth	  (TSB)	  and	  then	  inoculated	  into	  a	  3	  %	  TSB	  suspension	  and	  agar	  slants	  composed	  of	  3	  %	  
TSB	  and	  1.5	  %	  Tryptic	  Soy	  Agar	  (TSA).	  	  The	  suspension	  and	  slants	  were	  incubated	  for	  24	  h	  at	  37	  
°C.	  	  The	  slants	  were	  placed	  in	  a	  4	  °C	  cold	  room	  for	  long	  term	  storage.	  	  From	  the	  suspension,	  2	  
mL	  of	  E.	  coli	  grown	  overnight	  was	  inoculated	  into	  two	  flasks	  containing	  100	  mL	  and	  500	  mL	  of	  
TSB	  and	  incubated	  at	  37	  °C.	  	  The	  absorbance	  of	  the	  E.	  coli	  suspension	  was	  monitored	  over	  time,	  
and	  upon	  reaching	  exponential	  growth,	  the	  100	  mL	  flask	  was	  placed	  into	  the	  4	  °C	  cold	  room	  for	  
storage.	   	   At	   this	   time,	   the	   500	   mL	   flask	   was	   inoculated	   with	   PRD1	   and	   incubated	   at	   37	   °C	  
overnight	  to	  propagate	  the	  virus.	  	  	  
	  
The	  S.	   typhimurium	  was	   split	   into	   three	   cryovials	   for	   long	   term	   storage	   and	  one	   streak	  plate	  
which	   was	   incubated	   at	   37	   °C	   and	   then	   stored	   in	   a	   refrigerator.	   	   Multiple	   colonies	   of	   S.	  
typhimurium	  were	  removed	  from	  the	  streak	  plate	  by	  a	  wire	  loop	  and	  inoculated	  into	  500	  mL	  of	  
TSB.	   	   The	   suspension	  was	  grown	  overnight	   in	   a	  37	   °C	   shaker	   incubator.	   	   The	   suspension	  was	  
inoculated	  with	   0.5	  mL	   PRD1	   stock	   and	  was	   incubated	   at	   37	   °C	   overnight	   to	   allow	   for	   virus	  
replication.	  	  	  
	  
Stock	   solutions	   of	   PRD1	  were	   purified	   and	   concentrated	   using	   centrifugation,	  microfiltration,	  
and	  ultrafiltration	  to	  yield	  a	  high	  titer	  of	  PRD1.	  The	  virus-­‐host	  suspensions	  were	  centrifuged	  at	  
5000	   rpm	   for	   10	  minutes	   to	   separate	   the	   cellular	   debris	   into	   a	   pellet.	   	   The	   supernatant	  was	  
passed	   through	  a	  Stericup	  sterile	  vacuum	  filter	  unit	  with	  a	  polyvinylidene	   fluoride	  membrane	  
(PVDF)	  with	  a	  nominal	  pore	  size	  of	  0.22	  μm	  (Millipore,	  Billerica,	  MA)	  to	  remove	  debris	  that	  was	  
not	  removed	  during	  centrifugation.	   	  To	  remove	  dissolved	  matter	  from	  the	  virus	  stock,	  a	  PVDF	  
ultrafiltration	  (UF)	  membrane	  with	  nominal	  molecular	  weight	  cutoff	  of	  30	  kDa	  (HFM-­‐100;	  Koch	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Membrane	  Systems,	  Wilmington,	  MA)	  was	  mounted	  in	  a	  sterile	  Amicon	  stirring	  cell	  (Millipore,	  
Billerica,	  MA)	  and	  pressurized	  using	  air	  or	  nitrogen	  gas.	  	  The	  membrane	  was	  preconditioned	  by	  
passing	  200	  mL	  of	  nanopure	  water	  and	  50	  mL	  of	  1	  mM	  carbonate	  buffer	  solution	  (CBS)	  to	  flush	  
the	  system.	   	  The	   filtrate	   from	  the	  microfilter	  was	  poured	   into	   the	  stirring	  cell	  and	  then	  three	  
additions	  each	  of	  200	  mL	  of	  1	  mM	  CBS	  were	  filtered	  through	  the	  cell	  to	  continually	  remove	  the	  
dissolved	  organics.	   	  When	  the	  volume	  in	  the	  cell	  chamber	  reached	  about	  20	  mL,	  the	  filtration	  
was	  stopped,	  and	  the	  resulting	  virus	  solution	  was	  resuspended	  into	  150	  mL	  of	  1	  mM	  CBS	  and	  
aliquoted	  into	  50	  mL	  glass	  jars.	  	  The	  resulting	  stock	  was	  stored	  at	  4	  °C	  until	  used	  for	  disinfection	  
experiments.	   	  The	  final	  virus	  titer	  was	  about	  1	  ×	  10⁹	  plaque-­‐forming	  units	   (PFU)/mL	  for	  PRD1	  
propagated	   and	   assayed	   with	   E.	   coli	   and	   3.9	   ×	   10⁶	   PFU/mL	   for	   PRD1	   propagated	   with	   S.	  
typhimurium	  and	  assayed	  with	  E.	  coli.	  	  	  
	  
PRD1	  viability	  assessment	  was	  measured	  using	  the	  double	  agar	  layer	  plaque	  technique	  (Adams,	  
1959).	  	  The	  E.	  coli	  was	  grown	  from	  a	  stock	  flask	  on	  the	  day	  of	  the	  experiment	  until	  it	  reached	  an	  
exponential	  growth	  phase.	  	  Virus	  samples	  from	  experiments	  were	  serially	  diluted	  with	  TSB.	  	  In	  a	  
48	  °C	  water	  bath,	  glass	  vials	  were	  filled	  with	  3.5	  mL	  of	  soft	  agar,	  0.25	  mL	  of	  freshly	  grown	  E.	  coli,	  
and	  0.8	  mL	  of	  virus	  sample.	   	  The	  contents	  were	  gently	  swirled	  and	  quickly	  poured	  into	  a	  hard	  
agar	  petri	  dish.	  	  The	  plates	  were	  placed	  into	  a	  37	  °C	  incubator,	  and	  plaques	  were	  enumerated	  
between	   18	   and	   48	   h	   after	   plating.	   	   Virus	   titers	  were	   calculated	   by	   counting	   the	   number	   of	  
plaques	  on	  plates	  containing	  30-­‐300	  PFU/plate.	  	  	  
	  
	  
2.2	  	  Adenovirus	  Propagation	  and	  Viability	  Assessment	  	  	  
	  
Adenovirus	  serotype	  2	  (VR-­‐846)	  was	  propagated	  using	  human	  lung	  A549	  carcinoma	  cells	  (CCL-­‐
185)	   obtained	   from	   the	   American	   Type	   Culture	   Collection	   (Manassas,	   Virginia).	   	   Detailed	  
methods	   for	   adenovirus	   propagation	   and	   viability	   assessment	   as	   well	   as	   cell	   culture	   growth	  
were	  described	  previously	  (Sirikanchana	  et	  al.,	  2008).	  	  Monolayers	  of	  A549	  cells	  were	  grown	  on	  
flasks	   in	   a	   nutrient	   media	   containing	   a	   modified	   Ham’s	   F12K	   growth	   media	   in	   a	   5	   %	   CO₂	  
incubator.	   	   The	   nutrient	  media	   also	   contained	   10	  %	   fetal	   bovine	   serum,	   a	   fungizone,	   and	   an	  
antibiotic.	   	   Viruses	   were	   propagated	   by	   inoculating	   stock	   adenovirus	   solutions	   onto	   cell	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monolayers,	   incubating	   the	   flasks,	   and	   were	   released	   using	   the	   freeze-­‐thaw	   method.	   	   The	  
solution	  was	   then	  purified	  using	   centrifugation,	  microfiltration,	   and	  ultrafiltration	   to	  obtain	   a	  
high	  titer	  virus	  stock.	  	  Viability	  was	  measured	  using	  a	  plaque	  assay	  by	  plating	  adenovirus	  onto	  
A549	  cell	  monolayers	  with	  a	  nutrient	  mixture	  and	  a	  soft	  agar	  overlay	  technique.	   	  Plates	  were	  
then	  incubated,	  and	  plaques	  were	  quantified	  seven	  to	  ten	  days	  after	  plating.	  	  	  	  	  
	  
	  
2.3	  	  Chlorine	  Disinfection	  
	  
Free	   chlorine	   disinfection	   experiments	   were	   performed	   in	   a	   batch	   reactor	   following	   with	   a	  
similar	  procedure	  as	   that	  described	  by	  Page	  et	  al.	   (2009).	   	   Three	  batch	   reactors	   consisting	  of	  
sterile	   glass	   amber	   jars	   were	   used	   in	   each	   experiment.	   	   The	   reactors	   contained	   a	   100	   mL	  
volume	  of	  1	  mM	  CBS	  and	  were	  continuously	  stirred	  by	  magnetic	  mixing.	  	  The	  CBS	  was	  prepared	  
with	  nanopure	  water	  and	  the	  addition	  of	  sodium	  bicarbonate.	  	  Experiments	  were	  performed	  at	  
a	  pH	  ranging	  from	  8.3	  to	  10.0	  and	  temperatures	  of	  1°C	  and	  14°C.	  	  Experimental	  conditions	  can	  
be	   seen	   in	   Table	  1.	   	   Temperature	  was	   controlled	  by	  a	   recirculating	  water	  bath	  and	  was	   kept	  
within	  ±0.5	  °C	  of	  the	  desired	  temperature.	  	  	  
	  
In	   the	   first	   batch	   reactor	   (R1),	   a	   solution	   of	   sodium	   hypochlorite	   was	   added	   to	   achieve	   the	  
target	   dose	   of	   free	   chlorine.	   	   Throughout	   the	   time	   interval	   of	   the	   experiment,	   the	   chlorine	  
concentration	  was	  analyzed	  to	  determine	  the	  free	  chlorine	  dose	  and	  to	  confirm	  that	  there	  was	  
no	  chlorine	  demand	  in	  the	  reactor	  and	  therefore	  no	  decay	  over	  time.	  	  The	  pH	  in	  batch	  reactors	  
R2	  and	  R3	  was	  adjusted	  by	  the	  addition	  of	  0.1	  M	  sodium	  hydroxide	  or	  by	  diffusing	  or	  stripping	  
carbon	  dioxide.	   	  The	  pH	  was	  monitored	  before	  and	  after	  each	  experiment.	   	  The	  measured	  pH	  
values	  are	  shown	   in	  Table	  1	   for	  each	  experiment.	   	  Reactors	  R2	  and	  R3	  were	   immersed	   in	  the	  
water	   bath	   for	   about	   an	   hour	   to	   allow	   the	   experimental	   water	   to	   adjust	   to	   the	   target	  
temperature.	   	  Virus	  stock	  was	  then	  added	  to	  reactors	  R2	  and	  R3	  to	  achieve	  the	  desired	  initial	  
viral	   concentration,	   and	   the	   viruses	   were	   given	   additional	   time	   to	   acclimate	   to	   the	   pH	   and	  
temperature	  conditions.	  	  The	  purpose	  of	  reactor	  R2	  was	  to	  monitor	  the	  decay	  of	  free	  chlorine	  
over	  the	  duration	  of	  the	  experiment.	  	  The	  same	  volume	  of	  sodium	  hypochlorite	  solution	  added	  
to	  R1	  was	  added	  to	  R2,	  and	  the	  amount	  of	  free	  chlorine	  present	  was	  analyzed	  throughout	  the	  
	   	  	  	  8	  
experiment	   beginning	   from	   about	   10	   s	   after	   addition.	   	   Reactor	   R3	   was	   used	   to	   take	   viral	  
samples	   throughout	   the	   experiment	   to	   determine	   the	   inactivation	   of	   the	   virus.	   	   A	   control	  
sample	  (N0)	  was	  taken	  approximately	  five	  minutes	  before	  the	  addition	  of	  sodium	  hypochlorite	  
to	  quantify	  the	  initial	  virus	  concentration.	  	  The	  reactor	  was	  then	  dosed	  with	  the	  same	  volume	  of	  
sodium	  hypochlorite	  solution	  as	  R1	  and	  R2.	  	  Viral	  samples	  were	  taken	  from	  the	  reactor	  in	  1	  mL	  
volumes,	   and	   the	   chlorine	   in	   the	   sample	   was	   quenched	   using	   0.1	   mL	   of	   a	   0.1	   %	   sodium	  
thiosulfate	  solution.	   	  The	  time	  of	  quenching	  was	  recorded	  as	  the	  sample	  time.	   	  Samples	  were	  
also	  taken	  from	  R3	  to	  analyze	  the	  free	  chlorine	  concentration.	  	  	  	  	  	  	  	  
	  
Free	   chlorine	   concentration	  was	   quantified	   using	   the	  DPD	   colorimetric	  method	   (APHA	   et	   al.,	  
2005).	   	  Cuvettes	  with	  1	  cm	  path	  length	  were	  used	  to	  measure	  free	  chlorine	  concentrations	   in	  
the	  range	  of	  0.25-­‐1.5	  mg/L	  as	  Cl₂.	  	  Cuvettes	  with	  5	  cm	  path	  lengths	  were	  used	  to	  measure	  free	  
chlorine	  concentrations	  in	  the	  range	  of	  0.1-­‐0.25	  mg/L	  as	  Cl₂.	  	  It	  should	  be	  noted	  that	  in	  several	  
experiments,	   free	  chlorine	  concentration	  was	  fully	  quantified	  by	  using	  the	  R3	  reactor	  for	  viral	  
samples	  and	  free	  chlorine	  concentration.	  	  For	  these	  experiments	  R2	  was	  not	  used.	  	  	  	  
	  
	  
2.4	  	  Low	  Pressure	  Ultraviolet	  Light	  Disinfection	  
	  
Viruses	  were	  exposed	  to	  low	  pressure	  ultraviolet	  light	  using	  a	  collimated	  beam	  system	  (Calgon	  
Carbon	  Corporation,	  Pittsburg,	  PA)	  containing	  a	  low-­‐pressure	  Hg	  lamp.	  	  The	  incident	  light	  emits	  
a	   narrow	   emission	   spectra	   centered	   at	   254	   nm.	   	   Light	   intensity	   was	   measured	   using	   a	  
radiometer	   and	   the	   intensity	   was	   approximately	   I	   =	   0.046	   mW/cm².	   	   UV	   fluences	   were	  
determined	  by	  radiometry	  (Bolton	  and	  Linden,	  2003).	  	  A	  6	  cm	  diameter	  dish	  containing	  15	  mL	  
of	  1	  mM	  CBS	  was	  placed	  under	  the	  collimated	  beam.	  	  The	  reactor	  was	  continuously	  mixed	  by	  
magnetic	   stirring.	   	  Viruses	  were	  added	   to	   the	   reactor	   and	   samples	  were	   taken	  at	   various	  UV	  
doses.	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2.5	  	  Solar	  Disinfection	  
	  
Using	  a	  laboratory	  solar	  simulator,	  various	  filters	  were	  used	  to	  mimic	  conditions	  on	  a	  sunny	  day	  
in	  equatorial	  latitudes.	  	  A	  1000	  W	  Xenon	  arc	  lamp	  (Newport,	  Stratford,	  CT)	  was	  used	  to	  produce	  
a	  collimated	  light	  beam	  which	  was	  then	  passed	  through	  filters	  before	  reaching	  the	  reactor.	  	  The	  
filters	  used	  included	  an	  Air	  Mass	  0	  +	  1.5,	  a	  25	  %	  transmittance	  filter,	  and	  a	  >324	  nm	  long	  pass	  
filter.	   	  A	  UV-­‐vis	  radiant	  power	  meter	  (Newport,	   Irvine,	  CA)	  measured	   intensity	  of	  the	   incident	  
light.	  	  Experiments	  were	  performed	  in	  a	  100	  mL	  water-­‐jacketed	  batch	  reactor	  kept	  at	  25	  °C	  by	  a	  
recirculating	  water	  bath.	  	  The	  reactor	  contained	  25	  mL	  of	  1	  mM	  CBS	  and	  was	  continually	  mixed	  
by	  magnetic	  stirring	  under	  the	  incident	  light.	  	  	  Viruses	  were	  added	  to	  the	  reactor	  and	  samples	  
were	  taken	  over	  time.	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CHAPTER	  3	  RESULTS	  AND	  DISCUSSION	  
	  
	  
3.1	  	  Free	  Chlorine	  Disinfection	  
	  
	  
3.1.1	  	  Free	  chlorine	  concentration	  and	  exposure	  
The	  dosage	  or	  exposure	  to	  free	  chlorine	  was	  measured	   in	  terms	  of	  the	  CT	  concept.	  For	  some	  
reactors,	  the	  CT	  was	  quantified	  with	  the	  expression:	  !" = !"!! = !₀   !!!!!!!!! = !₀!!!! (1− !!!!!)!! 	  
	  
where	  C0	   is	  the	  initial	  free	  chlorine	  concentration,	  !! 	  is	  the	  first	  order	  decay	  constant	  for	  free	  
chlorine,	  t	   is	  the	  exposure	  time,	  and	  t’	   is	  an	  integration	  time	  variable	  (Page	  et	  al.,	  2009).	  	  This	  
equation	  describes	   the	   free	   chlorine	  decay	  by	   first-­‐order	   kinetics.	   	  However,	   it	  was	  observed	  
that	  chlorine	  underwent	  two	  phases	  of	  decay.	  	  The	  first	  phase	  resulted	  in	  an	  initial	  rapid	  decay	  
of	  chlorine.	  	  When	  the	  first	  chlorine	  sample	  was	  taken	  between	  5-­‐10	  s	  after	  chlorine	  addition,	  
the	   chlorine	   had	   already	   completed	   the	   initial	   rapid	   decay.	   	   Subsequent	   chlorine	   samples	  
confirmed	  that	   the	  chlorine	  was	  undergoing	  a	  second	  phase	  of	   slower	  decomposition	   for	   the	  
duration	   of	   the	   experiment.	   	   The	   CT	   values	   for	   these	   reactors	   were	   calculated	   using	   the	  
equation	   above,	   and	   by	   using	   the	   value	   obtained	   by	   extrapolating	   to	   the	   intercept	   at	   t=0	   to	  
determine	  C0.	  	  This	  predicted	  C0	  value	  was	  therefore	  lower	  than	  the	  initial	  dosage	  determined	  
by	   R1,	   and	   is	   attributed	   to	   the	   free	   chlorine	   demand	   occurring	   in	   the	   first	   phase	   of	  
decomposition.	  	  To	  support	  the	  validity	  of	  this	  approach,	  the	  r²	  value	  was	  determined	  for	  each	  
experiment.	  	  	  
	  
For	  some	  experiments,	  the	  concentration	  of	  free	  chlorine	  did	  not	  decay	  according	  to	  the	  above	  
expression,	  and	  the	  chlorine	  remained	  constant	  throughout	  the	  duration	  of	  the	  experiment.	  	  In	  
such	  cases	  an	  average	  C	  value	  was	  obtained.	  	  This	  occurred	  when	  a	  small	  volume	  of	  stock	  virus	  
solution	   was	   added	   to	   the	   reactor	   resulting	   in	   negligible	   chlorine	   decay.	   	   For	   some	   other	  
experiments,	   chlorine	   underwent	   two	   phases	   of	   decomposition,	   a	   first	   phase	   of	   initial	   rapid	  
decay	  followed	  by	  a	  second	  phase	  with	  no	  decay	  (concentrations	  remained	  within	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as	  Cl₂).	   	  When	  the	  first	  chlorine	  sample	  was	  taken	  between	  5-­‐10	  s	  after	  chlorine	  addition,	  the	  
initial	   phase	  of	   rapid	   chlorine	  decay	  was	  already	   completed.	   	   For	   these	   reactors,	   an	   initial	  C0	  
value	   was	   taken	   as	   the	   average	   C	   value	   and	   was	   therefore	   lower	   than	   the	   applied	   dose	  
determined	  in	  R1.	  	  	  	  
	  
3.1.2	  	  Effect	  of	  pH	  
The	  effect	  of	  pH	  on	  the	  inactivation	  kinetics	  of	  PRD1	  at	  1	  °C	  and	  14	  °C	  is	  presented	  in	  Figures	  1	  
and	  2,	  respectively.	  	  For	  both	  temperatures,	  pH	  has	  a	  relatively	  strong	  effect	  on	  the	  inactivation	  
of	   PRD1	   with	   free	   chlorine	   where	   more	   rapid	   inactivation	   occurs	   at	   decreasing	   pH	   values.	  	  
Experimental	  data	  at	  1	  °C	  was	  obtained	  for	  pH	  ranging	  from	  8.3	  to	  10.0.	  	  Slower	  inactivation	  of	  
PRD1	  occurred	  at	  increasingly	  higher	  pH	  values.	  	  For	  pH	  values	  lower	  than	  8.3,	  the	  inactivation	  
kinetics	   were	   so	   rapid	   that	   more	   than	   4	   logs	   of	   inactivation	   occurred	   before	   an	   initial	   viral	  
sample	  could	  be	  obtained.	  	  The	  data	  therefore	  could	  not	  be	  quantified.	  	  At	  high	  pH	  values,	  an	  
initial	   lag	   phase	   occurs	   and	   this	   lag	   phase	   seems	   to	   extend	   further	   at	   increasingly	   high	   pH	  
values.	  	  After	  the	  initial	  lag,	  at	  all	  pH	  values	  a	  more	  rapid	  inactivation	  phase	  occurs.	  	  The	  slope	  
of	  this	  more	  rapid	  inactivation	  decreases	  with	  increasing	  pH.	  	  For	  some	  experimental	  data	  sets,	  
a	  leveling	  off	  of	  inactivation	  is	  observed	  after	  4-­‐logs	  of	  inactivation.	  	  Current	  data	  suggests	  that	  
this	  leveling	  off	  may	  be	  consistent	  at	  all	  pH’s	  measured;	  however,	  it	  is	  currently	  unknown	  if	  the	  
virus	  is	  undergoing	  a	  slower	  rate	  of	   inactivation	  or	  if	  there	  is	  no	  additional	   inactivation	  at	  this	  
point.	   	   Variability	   was	   observed	   at	   different	   pH	   values,	   especially	   at	   pH	   10.	   	   This	   is	   being	  
attributed	  to	  a	  lack	  of	  sensitivity	  in	  the	  pH	  probe	  at	  low	  temperatures,	  and	  further	  experiments	  
will	   be	  performed	   to	  verify	  data.	   	   Similar	   trends	  were	  observed	  at	  14	   °C	  over	  a	  narrower	  pH	  
range	  of	  9.2	  to	  10.	  	  	  	  	  
	  
3.1.3	  	  Effect	  of	  temperature	  
The	  effect	  of	  temperature	  on	  the	  inactivation	  of	  PRD1	  was	  measured	  over	  a	  range	  of	  pH	  values	  
at	  1	  °C	  and	  14	  °C.	  	  At	  the	  higher	  temperature,	  PRD1	  underwent	  more	  rapid	  inactivation	  kinetics	  
which	  was	  expected.	   	  Similar	  slopes	  of	   inactivation	  were	  observed	  when	  comparing	  the	  same	  
pH	  values	  at	  the	  different	  temperatures.	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3.1.4	  	  Effect	  of	  initial	  virus	  and	  free	  chlorine	  concentrations	  
The	   effect	   of	   initial	   virus	   concentration	   (N0)	   on	   the	   inactivation	   kinetics	   of	   PRD1	   with	   free	  
chlorine	  was	   determined	  by	   adding	   varying	   initial	   concentrations	   of	   viruses	   for	   reactors	  with	  
the	   same	   pH	   and	   temperature	   conditions.	   	   The	   variability	   between	   experiments	   is	   similar	   to	  
that	  obtained	  at	  constant	  N0	  and	  so	  it	  is	  not	  attributed	  to	  the	  concentration	  of	  viruses	  initially	  
added	  in	  the	  reactors.	  	  The	  CT	  concept	  was	  verified	  by	  varying	  the	  initial	  chlorine	  concentration	  
added	   to	   the	   reactors	   at	   the	   same	   pH	   and	   temperature	   conditions.	   	   A	  more	   comprehensive	  
analysis	  will	  be	  done	  by	  performing	  additional	  experiments.	  	  	  
	  
3.1.5	  	  Comparison	  of	  PRD1	  and	  adenovirus	  inactivation	  kinetics	  with	  free	  chlorine	  
The	   trends	   and	   overall	   behavior	   of	   the	   inactivation	   kinetics	   of	   PRD1	   when	   exposed	   to	   free	  
chlorine	   are	   similar	   to	   those	   of	   adenovirus	   as	   seen	   in	   Figure	   3.	   	   For	  most	   conditions	   tested,	  
PRD1	   undergoes	   somewhat	   faster	   inactivation	   kinetics	   compared	   to	   adenovirus.	   	   Similar	   to	  
adenovirus,	  at	  higher	  temperatures,	  PRD1	  kinetics	  are	  quicker	  than	  at	  low	  temperatures.	  	  The	  
CT	  value	  required	  for	  achieving	  4	   logs	  of	   inactivation	  for	  PRD1	  and	  adenovirus	   is	  very	   low	  for	  
the	  conditions	   tested	  and	  shows	  that	   they	  both	  have	  similarly	   rapid	   inactivation	  kinetics	  with	  
free	   chlorine.	   	   Using	   PRD1	   as	   a	   tool	   for	   elucidating	   the	   mechanisms	   of	   inactivation	   of	  
adenovirus	   by	   free	   chlorine	   may	   be	   a	   viable	   option	   based	   on	   this	   data	   and	   especially	  
considering	  their	  similar	  morphologies.	  
	  
	  
3.2	  	  Low	  Pressure	  Ultraviolet	  Light	  Disinfection	  
	  
PRD1	  was	  inactivated	  using	  low	  pressure	  ultraviolet	  light.	  	  The	  resulting	  inactivation	  kinetics	  is	  
shown	   in	   Figure	   4	   together	  with	   the	   kinetics	   for	   other	   viruses.	   	   The	   PRD1	   viruses	   used	  were	  
propagated	  using	  hosts	  E.	  coli	  K-­‐12	  and	  S.	  typhimurium	  LT2	  to	  form	  different	   lipids	  within	  the	  
virus.	  	  Viruses	  were	  only	  plated	  with	  host	  E.	  coli	  K-­‐12	  during	  experiments.	  	  For	  both	  virus	  types	  
tested,	   a	   4-­‐log	   inactivation	   of	   PRD1	   was	   achieved	   at	   about	   40	   mJ/cm².	   	   These	   data	   are	  
consistent	  with	  data	  by	  Meng	  and	  Gerba	  (1996)	  which	  show	  a	  4-­‐log	  inactivation	  of	  PRD1	  with	  a	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dose	  of	  31.6	  mJ/cm².	   	  The	  host	  bacteria	  used	  by	  Meng	  and	  Gerba	  (1996)	  was	  S.	  typhimurium	  
LT2.	   	   Data	   from	   a	   study	   by	   Shin	   et	   al.	   (2005)	   shows	   a	   4-­‐log	   inactivation	   of	   PRD1	   with	   S.	  
typhimurium	   LT2	   as	   a	   host	   at	   an	   approximate	   dose	   of	   105	   mJ/cm².	   	   	   Shin	   et	   al.	   (2005)	  
hypothesize	  that	  the	  differences	  between	  their	  study	  and	  the	  Meng	  and	  Gerba	  (1996)	  study	  in	  
the	  sensitivity	  of	  PRD1	  to	   low	  pressure	  ultraviolet	   light	  may	  depend	  on	  how	  the	  viruses	  were	  
prepared	  and	  purified	  and	  if	  they	  were	  exposed	  to	  repeated	  freezing	  and	  thawing.	  	  Both	  studies	  
used	  S.	  typhimurium	  LT2	  as	  the	  host	  bacteria	  for	  propagation	  and	  enumeration,	  whereas	  in	  this	  
study	  E.	  coli	  K-­‐12	  was	  used	  as	   the	  host	  bacteria	   for	  enumeration.	   	  The	  other	  main	  difference	  
between	  this	  study	  and	  the	  previous	  studies	   is	  the	  PRD1	  propagation	  method.	   	  Both	  previous	  
studies	  inoculated	  PRD1	  and	  host	  bacteria	  with	  molten	  agar	  onto	  pre-­‐solidified	  TSA	  petri	  dishes,	  
let	   incubate,	   and	   then	   harvested	   phages	   from	   the	   plates	   which	   required	   the	   addition	   of	  
chloroform	  or	  Tris-­‐buffered	  saline.	  	  Lastly,	  the	  test	  waters	  for	  the	  research	  by	  Shin	  et	  al.	  (2005)	  
were	  different.	  	  PRD1	  was	  suspended	  in	  coagulated	  and	  filtered	  surface	  water	  from	  the	  Greater	  
Cincinnati	  Water	  Works	   utility	   in	   Cincinnati,	   Ohio.	   	   This	   may	   have	   also	   played	   a	   role	   in	   the	  
different	   inactivation	   kinetic	   data	   as	   the	   water	   used	   in	   this	   study	   was	   nanopure.	   	   Further	  
experiments	  will	  be	  performed	  to	  determine	  if	  the	  efficacy	  of	  PRD1	  disinfection	  depends	  on	  the	  
host	  bacteria	  during	  plating	  and	  the	  type	  of	  water	  used.	  	  	  	  
	  
The	  inactivation	  kinetics	  of	  PRD1	  with	  low	  pressure	  UV	  was	  compared	  to	  that	  of	  other	  DNA	  and	  
RNA	  viruses.	  	  Figure	  4	  shows	  that	  PRD1	  does	  not	  have	  similar	  inactivation	  kinetics	  to	  adenovirus	  
serotype	  2	  (Sirikanchana	  et	  al.,	  2008).	  	  PRD1	  reaches	  4-­‐log	  inactivation	  about	  four	  times	  faster	  
than	   adenovirus.	   	   Interestingly,	   Figure	   4	   shows	   that	   the	   inactivation	   kinetics	   behaves	   very	  
similarly	   to	   the	  single-­‐stranded	  RNA	  Coxsackie	  virus	  B5	  with	  about	   the	  same	  dosage	  required	  
for	   4-­‐log	   inactivation	   (Vonder	   Haar,	   2009).	   	   PRD1	   would	   be	   an	   effective	   surrogate	   for	   this	  
human	  enteric	  pathogen	  for	  low	  pressure	  UV.	  	  The	  typical	  bacteriophage	  surrogate	  used	  for	  low	  
pressure	  UV	  is	  the	  single-­‐stranded	  RNA	  genome	  bacteriophage	  MS2.	  	  As	  the	  figure	  shows,	  this	  
phage	  does	  not	  exhibit	  similar	  inactivation	  kinetics	  as	  Coxsackie	  virus	  B5	  or	  adenovirus	  serotype	  
2,	  and	  MS2	  is	  more	  resistant	  to	  LPUV	  than	  PRD1	  (Coronell,	  2004).	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3.3	  	  Solar	  Disinfection	  
	  
PRD1	  shows	  a	  similar	  resistance	  to	  solar	  disinfection	  compared	  to	  adenovirus	  type	  2	  as	  shown	  
in	   Figure	   5.	   	   A	   preliminary	   adenovirus	   experiment	   revealed	   that	   after	   2.6	   h	   exposure	   to	  
simulated	  sunlight,	  less	  than	  0.5-­‐log	  inactivation	  occurred.	  	  PRD1	  was	  then	  exposed	  to	  48	  h	  of	  
continuous	  simulated	  sunlight	  and	  only	  about	  2.8-­‐log	  inactivation	  was	  achieved.	  	  With	  16	  h	  of	  
full	   sunlight	  exposure,	  PRD1	  only	  reaches	  about	  1-­‐log	   inactivation.	   	  This	   further	  confirms	  that	  
SODIS	  exposure	  for	  one	  to	  two	  days	  (8	  to	  16	  h	  of	  sunlight)	  will	  not	  be	  effective	  for	  all	  viruses,	  
and	  alternative	  disinfectants	  are	  necessary	  to	  achieve	  4-­‐log	  inactivation.	  	  PRD1	  is	  potentially	  a	  
good	  surrogate	  for	  adenovirus	  when	  exposed	  to	  sunlight.	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Table	  1:	  	  Experimental	  conditions	  for	  PRD1	  with	  free	  chlorine	  
Experiment	  







(mg/L	  as	  Cl₂)	  
Dose	   Co	  
28	   10/6/10	   8.3	   8.33-­‐8.25	   1	   5.00E+05	   0.166	   0.167	  
27	   10/6/10	   8.5	   8.54-­‐8.39	   1	   7.25E+05	   0.166	   0.160	  
23	   9/24/10	   8.7	   8.72-­‐8.70	   1	   5.75E+05	   0.307	   0.305	  
32	   10/15/10	   8.85	   8.84-­‐8.88	   1	   1.69E+06	   0.393	   0.384	  
19	   9/15/10	   9.0	   9.05-­‐9.05	   1	   9.50E+05	   0.610	   0.595	  
21	   9/20/10	   9.0	   9.01-­‐9.10	   1	   1.45E+06	   0.478	   0.449	  
4	   7/17/10	   9.2	   9.24-­‐9.21	   1	   1.15E+06	   0.461	   0.311	  
22	   9/22/10	   9.2	   9.24-­‐9.20	   1	   1.06E+06	   0.423	   0.401	  
31	   10/14/10	   9.2	   9.24-­‐9.21	   1	   1.43E+06	   0.415	   0.373	  
12	   8/13/10	   9.6	   9.62-­‐9.65	   1	   4.28E+06	   0.640	   0.472	  
13	   8/14/10	   9.6	   9.56-­‐9.45	   1	   3.72E+06	   0.640	   0.446	  
24	   9/27/10	   9.6	   9.60-­‐9.55	   1	   7.00E+05	   0.420	   0.376	  
26	   10/4/10	   9.8	   9.83-­‐9.86	   1	   5.25E+05	   0.377	   0.342	  
29	   10/7/10	   9.8	   9.83-­‐9.89	   1	   1.13E+06	   0.350	   0.344	  
33	   10/19/10	   10.0	   9.97-­‐10.00	   1	   8.50E+05	   0.390	   0.391	  
37	   11/1/10	   9.2	   9.20-­‐9.17	   14	   1.70E+06	   0.448	   0.410	  
35	   10/28/10	   9.6	   9.59-­‐9.59	   14	   9.63E+05	   0.404	   0.398	  
36	   11/1/10	   9.6	   9.59-­‐9.54	   14	   1.51E+06	   0.448	   0.411	  
38	   11/2/10	   10.0	   10.03-­‐10.03	   14	   7.75E+05	   0.508	   0.501	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Figure	  1:	  	  Inactivation	  kinetics	  of	  PRD1	  with	  free	  chlorine	  at	  1	  °C	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Figure	  2:	  	  Inactivation	  kinetics	  of	  PRD1	  with	  free	  chlorine	  at	  14	  °C	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Figure	  3:	  	  Comparison	  of	  inactivation	  kinetics	  of	  PRD1	  and	  adenovirus	  2	  at	  1	  °C	  and	  pH	  8.0-­‐10,	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Figure	  5:	  	  Comparison	  of	  inactivation	  of	  PRD1	  and	  adenovirus	  with	  simulated	  solar	  
disinfection	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CHAPTER	  4	  CONCLUSIONS	  AND	  FUTURE	  WORK	  
	  
	  
This	  research	  has	  examined	  the	  inactivation	  kinetics	  of	  PRD1	  in	  comparison	  to	  adenovirus	  for	  its	  
use	   as	   a	   potential	   surrogate	   in	   laboratory	   and	   field	   studies.	   	   Inactivation	   kinetics	   data	   were	  
presented	  for	  PRD1	  when	  exposed	  to	  doses	  of	  free	  chlorine,	  low	  pressure	  ultraviolet	  light,	  and	  
sunlight.	  	  	  
	  
PRD1	   appears	   to	   be	   a	   promising	   candidate	   surrogate	   for	   adenovirus	   for	   free	   chlorine	  
disinfection	  even	  though	  their	  kinetics	  are	  somewhat	  different	  because	  the	  trends	  and	  overall	  
behavior	  of	  the	   inactivation	  kinetics	  are	  very	  similar	  to	  those	  of	  adenovirus.	   	  Using	  PRD1	  as	  a	  
surrogate	  for	  adenovirus	  to	  elucidate	  the	  mechanism	  of	  inactivation	  by	  free	  chlorine	  may	  be	  a	  
viable	   option	   especially	   considering	   their	   similar	   capsid	   structures.	   	   Furthermore,	   at	   higher	  
temperatures	   such	   as	   those	   expected	   in	   developing	   regions,	   PRD1	   may	   be	   a	   promising	  
surrogate	   for	   fieldwork.	   	  Some	  variability	   in	  data	  at	   low	  temperatures	   is	  attributed	   to	   the	  pH	  
probe	   lacking	   sensitivity	   at	   very	   low	   temperatures;	   therefore,	  more	   robust	   data	   sets	   will	   be	  
produced	   in	   future	   research	  phases.	   	  A	  model	   to	  predict	  PRD1	   inactivation	  when	  exposed	   to	  
free	  chlorine	  will	  be	  developed	  and	  will	  be	  compared	  to	  that	  of	  adenovirus.	  	  	  
	  
For	   low	   pressure	   ultraviolet	   light,	   PRD1	   is	   a	   better	   surrogate	   for	   RNA	   viruses	   than	   for	  
adenovirus.	   	  Adenovirus	   requires	   four	   times	   the	   low	  pressure	  UV	  dose	   that	  PRD1	   requires	   to	  
reach	   4-­‐logs	   of	   inactivation.	   	   Since	   low	   pressure	   UV	   has	   been	   suggested	   to	   affect	   the	   viral	  
genome,	  the	  reason	  for	  PRD1	  having	  similar	  inactivation	  kinetics	  as	  RNA	  viruses	  will	  need	  to	  be	  
explored.	  	  It	  is	  also	  possible	  that	  different	  host	  cells	  may	  have	  the	  ability	  to	  repair	  DNA	  damage	  
in	  the	  virus	  and	  restore	  its	  viability.	  	  Future	  experiments	  will	  be	  performed	  using	  S.	  typhimurium	  
LT2	  as	  the	  host	  to	  see	  if	  this	  host	  bacteria	  results	   in	  different	  inactivation	  kinetics.	   	  This	  could	  
also	  be	  explored	  for	  the	  range	  of	  PRD1	  host	  bacteria	  to	  see	  if	  there	  is	  an	  appropriate	  surrogate-­‐
host	  combination	  to	  exhibit	  similar	  inactivation	  kinetics	  as	  adenovirus.	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Both	  adenovirus	  and	  PRD1	  are	  highly	   resistant	   to	   solar	  disinfection.	   	  PRD1	  can	  potentially	  be	  
used	   as	   a	   surrogate	   in	   the	   field	   to	   assess	   disinfection	   technologies	   like	   SODIS	   in	   developing	  
regions.	   	   Further	   research	  will	   be	   done	   to	   determine	   the	   inactivation	   kinetics	   of	   PRD1	  when	  
exposed	   to	  monochloramine	   in	   tandem	  with	   SODIS	   to	   determine	   if	   a	   synergistic	   relationship	  
exists	  similarly	  to	  adenovirus	  (Page,	  2009).	   	   If	  PRD1	  is	  found	  to	  be	  a	  nonpathogenic	  surrogate	  
for	  adenovirus	  disinfection	  with	  monochloramine	  and	  SODIS,	  such	  finding	  would	  be	  beneficial	  
to	  laboratory	  and	  field	  testing.	  	  	  	  	  
	  
An	  overall	  goal	  of	  this	  research	  is	  to	  obtain	  a	  better	  understanding	  of	  how	  disinfectants	  act	  on	  a	  
molecular	  level.	  	  This	  will	  allow	  the	  development	  of	  simple,	  appropriate,	  and	  robust	  disinfection	  
technologies	  to	  provide	  safe	  drinking	  water	  in	  developing	  regions.	  	  As	  more	  viruses	  are	  studied	  
in	   the	   laboratory	   after	   exposure	   to	   various	   disinfectants,	   trends	   between	   virus	   inactivation	  
kinetics	   are	   being	   observed	   which	   hopefully	   will	   aid	   in	   understanding	   the	   mechanism	   of	  
inactivation	  of	  human	  viruses.	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?($58 $ ?(?AS ?(8SV 4(AA
?(4S? $ ?(?V4 ?(8T5
$(AVA $ ?(?V5 ?(8T8
T(VVA $ ?(?VA ?(8$5
8(A$A $ ?(?VA ?(8$5 4(V$
?(VVA $ ?(?AT ?(8RT ,/%<;7@G%6'%,.U> ?(8RR
T(T$A $ ?(?V8 ?(T44 NL%<;01WX> ?(?T4
8(85888888 $ ?(?VA ?(8$5 "Y ?(S$V
-&*.&#&/+
%0 QECB6.%:0;+ ? 9$ 9T 98 9R 9S O O@O/ ,:%<;7Z;01@G>
$ ?(?? :O:, 4? S $$TS??? $ 0
T ?($S :O:, 84 R R5AS?? ?(R8888888 0.051487933
8 ?(8? :O:, 5S 5 $?VTS?? ?(4RRRRRRR 0.102752379
R ?(R5 :O:, :O:, A? 5AS??? ?(AAAAAAA5 0.16510684
S ?(5S :O:, T5S 8R 84?VTS ?(8RATTTTT 0.2888256
V $(R? :O:, 4S 5 $$5AS? ?($?SSSSSV 0.471954496
A $(58 :O:, A8 $? 4$TS ?(??5$$$$$ 0.614194654
5 T(R? 45 R $ $TT(S ?(???$?554 0.797524238
4 T(VVVVVVVA $$R T? ? $RT(S ?(???$TVVA 0.882760047
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Experiment	  number	  31	  
















?(5QR $ ?(?SS ?(9$S
$(5$R $ ?(?SR ?(9$T











?($ST $ ?(?ST ?(T49 4(5?
?(9?? $ ?(?RV ?(TVQ
$(V?? $ ?(?RS ?(TR$
5(?QR $ ?(?RR ?(TQQ 4(5?
$($TT $ ?(?S5 ?(T4?





%0 PDBA6.%<0=+ ? :$ :5 :T :9 :V N N@N/ ,<%8=7W=01@F;
$ ?(?? <N<, $$9 $5 $95V??? $ 0
5 ?($V <N<, $TT S $QQ5V?? $($QQQQQQR 0.055938242
T ?(5R <N<, <N<, Q5 RRV??? ?(V9TSV4QV 0.099445764
9 ?(9? $TV $RR $S $$4?Q5(V ?(?STVV5QT 0.149168646
V ?(V5 <N<, 55$ $? ? 5RQ5V ?(?$4TSV4Q 0.192676168
Q ?(QR <N<, 5V9 $5 ? T$RV ?(??555S?R 0.24861441
R ?(S5 9 VT ?
S $(?? $Q $ ?
4 $(5STTTTTT 95 T V5(V T(QS95X:?V 0.47858274
$? $(9$QQQQQR $9 $
$$ $(V$QQQQQR VV ? QS(RV 9(S59QX:?V 0.565597783
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Experiment	  number	  32	  
	  
















?($RS $ ?(?48 ?(TPP
$(?RS $ ?(?4U ?(TP?









?($RS $ ?(?4$ ?(T45 4(44
?(8RS $ ?(?SR ?(TR$
?(4$S $ ?(?S8 ?(T5U 4(4? ,/%<;7@F%6'%,.V> ?(T48
$($RS $ ?(?SU ?(T8U MK%<;01WX> ?(?PR
$(T5? $ ?(?SU ?(T8U "Y ?(P?5
-&*.&#&/+
%0 QDBA6.%:0;+ ? 9$ 9U 9T 98 95 N N@N/ ,:%<;7Z;01@F>
$ ?(?? :N:, $T5 5 $R4S5?? $ 0
U ?($U :N:, :N:, R4 45???? ?(5?TS?TS 0.044550054
T ?(UU :N:, :N:, R5 5 4$U5? ?(?84$84$5 0.082340688
8 ?(TT :N:, $8T T ? ? $S4S(5 ?(??$?5PUR 0.125973672
5 ?(85 5$ R ? ? RT(S5 T(SSS4[9?5 0.169120692
R ?(54 R$ U $ SR(U5 8(5$45[9?5 0.217843456
S ?(SU P $ ?














































	   	  	  	  39	  
Experiment	  number	  33	  
















4(PPP $ 4(4QP 4(P8R
$(PPP $ 4(4QS 4(P84








4(ST4 $ 4(4QT 4(R4R
$(P44 $ 4(499 4(PVV ,/%7=6?E%5'%,.U; 4(P8$
S(RQP $ 4(499 4(PVV LJ%7=01WX; 4(4S
P(QV9 $ 4(49V 4(PV$ "Y 4(V4R
R(Q44 $ 4(49V 4(PV$
-&*.&#&/+
%0 OCA@5.%<0=+ 4 :$ :S :P :R :T M M?M/ ,<%7=6Z=01?E;
$ 4(44 <M<, VQ 8 QT4444 $ 0
S 4(RP R9S S9 RVP9T4 4(TRTTQQSR 0.168701239
P 4(QP R48 PR RST444 4(T 0.323133078
R $(TT <M<, $SV R $T9T44 4($QTS8R$S 0.596752546
T S($P $8V Q 4 SRT44 4(4SQQSPTP 0.816588894
V S(9T RT Q S 4 TVS(T 4(444VV$9V 1.046215358
9 P(PP T $ 4
Q P(V9 R 4 4
8 R(4PPPPPPP S $ 4
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Experiment	  number	  35	  
















@(T5U $ @(@C8 @(?@?
$(BCT $ @(@C8 @(?@?









@(B@@ $ @(@C8 @(?@? 4(8@
@(?TT $ @(@CB @(T4@
@(UTT $ @(@C$ @(TC8 ,/%<;7AI%6'%,.V> @(T4C
@(U5U $ @(@C$ @(TC8 PN%<;01WX> @(@TB
B(@8@ $ @(@U4 @(TU8 "Y @(U??
-&*.&#&/+
%0 SGED6.%:0;+ @ 9$ 9B 9T 9? 98 Q QAQ/ ,:%<;7Z;01AI>
$ @(@@ :Q:, UU B 45B8@@ $ 0
B @($T :Q:, :Q:, :Q:, TC8 T@ TU8@@@ @(TC45$@T4 0.052953619
T @(B8 :Q:, :Q:, :Q:, $?8 B$ $C$B8@ @($CCT$$54 0.099103059
? @(TC :Q:, :Q:, BBC T4 TC5B8 @(@?@$B4CU 0.151634739
8 @(8@ :Q:, T$4 ?5 T 8U8@ @(@@84U?@T 0.197416457
5 @(4U ? @ @
U $($C @ @








































































A(:RR $ A(A4: A(::S
$(:AA $ A(A4: A(::S











A($VR $ A(AV5 A(:A4 4(8A
A(:$S $ A(AV8 A(:A:
A(S5S $ A(AV: A(R44
A(4VR $ A(A4A A(:TV





%0 QECB6.%;0<+ A 9$ 9T 9R 9: 98 O O@O/ ,;%=<7W<01@G?
$ A(AA ;O;, $T$ $$ $8$T8AA $ 0
T A($T ;O;, ;O;, 58 V$T8AA A(8RS$4AAV 0.04799683
R A(TR ;O;, ;O;, :A 8AAAAA A(RRA8SV8$ 0.09599367
: A(R8 ;O;, ;O;, $T: $88AAA A($AT:S4R: 0.1439905
8 A(:V ;O;, ;O;, ;O;, RV :S8AA A(AR$:A:45 0.19884402
5 A(5T ;O;, TVS RA R55V(S8 A(AAT:T85T 0.25369755
S A(SR RRV 5 :TT(8 A(AAATS4R: 0.30169438
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Experiment	  number	  37	  
















9(@RR $ 9(94@ 9(@@;
$(@99 $ 9(94@ 9(@@;









9($V; $ 9(9U; 9(@$R 4(59
9(@99 $ 9(9US 9(@9@
9(;$; $ 9(9US 9(@9@
$($99 $ 9(9U; 9(@$R





%0 QECB6.%=0>+ 9 :$ :5 :R :@ :S O OAO/ ,=%8>7W>01AG<
$ 9(99 =O=, $RV 59 $;99999 $ 0
5 9($9 =O=, =O=, =O=, @$ S$5S99 9(R9$@;9S4 0.040950119
R 9(5R =O=, =O=, =O=, R; V @V5S9 9(95;59SUU 0.095550277
@ 9(RS =O=, UV $$ 5 $9;S 9(999VR5RS 0.143325416
S 9(@; $ 9 9 9
V 9(V9 9 9 9
; 9(;5 9 9
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Experiment	  number	  38	  
















4(>R4 $ 4($4S 4(R$7
$(7$T $ 4($4U 4(R4>








4(7R4 $ 4($4R 4(>PP
$(RUT $ 4($47 4(>SP ,/%;:6?F%5'%,.V= 4(R4$
@(U$T $ 4($4$ 4(>S4 MK%;:01WX= 4(4$R
7(U$T $ 4($44 4(>TR "Y 4(PSP
-&*.&#&/+
%0 QDBA5.%90:+ 4 8$ 8@ 87 8> 8R N N?N/ ,9%;:6Z:01?F=
$ 4(44 9N9, U@ $ TTR444 $ 0
@ 4($S 9N9, 7$> @T 7UR444 4(>T4PUTT> 0.091723822
7 4(R4 9N9, 9N9, $US $P @$4444 4(@T4PUTT> 0.249562969
> 4(TR 9N9, 9N9, 9N9, $$S $> $>TR44 4($P47@@RS 0.37364431
R $(4@ 9N9, 9N9, @4P @> @ @U$@R 4(477T4PUS 0.505485874
U $(77 9N9, $S7 @4 R @@ST(R 4(44@PR$U$ 0.661364312
T $(S4 $$ $ $ 4
S @(7R T $ 4
P @(TS777777 $ 4 4
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APPENDIX	  B.	  	  RAW	  DATA:	  	  INACTIVATION	  OF	  PRD1	  WITH	  LPUV	  	  













?<7/%@7<A'B . C$ C, CD CE C6 CF CG #3'/%@7H-17I,B !J*-7) K-K3
. ?K?9 $DG ,, . . ,(,DLM.G $
E5D. ?K?9 ?K?9 ?K?9 ?K?9 NG $, . . $.(N $(.OLM.F .(.ENGDOEOF
O5.$ ?K?9 ?K?9 ?K?9 ?K?9 ,6 , . $ ,. D($DLM.6 .(.$E..6F.,





?<70%@7<A'B #4'0%@7C-27D.B , E$ E. EF EG E/ EH !I*-7) J-J4
, , ?J?9 KG $L L./,,,, $
G(F$HHHHK $, ?J?9 $.$ $K $/$./,, ,($HF/$G
M(HFFFFFF ., ?J?9 $HL $H .$$./, ,(,..MFM
$.(L/ F, ?J?9 $KF $/ .$H./ ,(,,.FFM
$K(.HHHHK G, ?J?9 LL M $.FK(/ ,(,,,$FG





@=80%A8=B'C #4'0%A8D-28E.C , F$ F. FG FH F7 !I*-8) J-J4
, , @J@: $./ $. $K$.7,, $
.($7 7 @J@: @J@: HL 7ML7,, ,(GKHGH$
K(HKKKKKL $7 @J@: @J@: K. L LL7,, ,(,HM,K.
$,(LMGGGG .7 @J@: 7K H L,,, ,(,,HGH$
$7(. G7(. GG7 LL H /K.(7 ,(,,,7/L
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B/),-C)/+&D #*&,-C)E79)F8D 6 G$ G8 GH GI G< !J47)3 K7K*
6 6 $I8 88 $ $LL<66 $
I28< $6 BKB> BKB> 8$8 M $ 8N<66 62$IM8MN
O2IOHHHHH 86 BKB> 8I$ 8N 6 6 H6$82< 626$NML8





B/),-C)/+&D #*&,-C)E7:)F8D 6 G$ G8 GH GI G9 !J47)3 K7K*
6266 6 $LH $M 8 8I$896 $
82$M 9 BKB> MM L LN896 62HLOLNI
N2IO $9 BKB> M6 $$ OM96 626HN8NL
$62O6 89 BKB> $8L N $N$829 6266NNOI
$92$8 H9 NL $6 ON289 62666H9O





C@),-D)@+&E #*&,-D)F47)G5E 3 H$ H5 HI HJ H; !K14)0 L4L*
3/33 3 53M 5I I 5;NM;3 $
J/I5 $3 5IM 5I 5 56O5; 3/$$JJ6I
N/OI 53 IN6 53 $
$5/6; I3 IIJ JO 5 ;M; 3/335555
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PRD1 vs. SODIS





PRD1 added: 0.10 mL
Temp 25°C
Intensity: 136.1mW
Sample No. Time (hrs) 0 -1 -2 -3 -4 -5 -6 N N/No
1 0 TNTC 63 8 7875000 1
2 1 TNTC 38 0 4750000 0.6031746
3 5 TNTC 147 16 1 1837500 0.23333333
4 15 TNTC TNTC TNTC TNTC 71 9 2 887500 0.11269841
5 24 TNTC TNTC TNTC 189 15 4 0 236250 0.03
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Ad2 added: 0.10 mL
Temp 25°C
Intensity: 107 mW/cm!
Time (hrs) 0 -1 -2 -3 -4 -5 -6 N N/No
1 0 8 0 0 100000 1
2 0.66666667 83 0 0 0 103750 1.0375
3 1.33333333 42 0 0 0 52500 0.525
4 2 TNTC 43 0 0 53750 0.5375






!$ !"%$ #$ #"%$ &$ &"%$ '$
!
"!
#$
%&'($#)$*#+,+-#-.$.-+/&012$31#-4.5$
6+7*,87,#+$#)$9:;$<&21$=>?6=$
